335 related articles for article (PubMed ID: 17227974)
1. Raloxifene vs tamoxifen.
Goldstein SR
JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
[No Abstract] [Full Text] [Related]
2. Another selective estrogen-receptor modulator for osteoporosis.
Becker C
N Engl J Med; 2010 Feb; 362(8):752-4. PubMed ID: 20181977
[No Abstract] [Full Text] [Related]
3. Selective estrogen receptor modulators and prevention of invasive breast cancer.
Gradishar WJ; Cella D
JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
[No Abstract] [Full Text] [Related]
4. [Evidence of raloxifene on postmenopausal osteoporosis].
Okano H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
[No Abstract] [Full Text] [Related]
5. Bone builder vs. breast cancer.
Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
[No Abstract] [Full Text] [Related]
6. Raloxifene examined for breast cancer prevention.
Young D
Am J Health Syst Pharm; 2007 Sep; 64(17):1774. PubMed ID: 17724350
[No Abstract] [Full Text] [Related]
7. Selective oestrogen receptor modulation: molecular pharmacology for the millennium.
Levenson AS; Jordan VC
Eur J Cancer; 1999 Dec; 35(14):1974-85. PubMed ID: 10711240
[TBL] [Abstract][Full Text] [Related]
8. Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene.
Vogel VG
Clin Interv Aging; 2008; 3(4):601-9. PubMed ID: 19281053
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Cecchini RS; Atkins JN; Bevers TB; Fehrenbacher L; Pajon ER; Wade JL; Robidoux A; Margolese RG; James J; Lippman SM; Runowicz CD; Ganz PA; Reis SE; McCaskill-Stevens W; Ford LG; Jordan VC; Wolmark N;
JAMA; 2006 Jun; 295(23):2727-41. PubMed ID: 16754727
[TBL] [Abstract][Full Text] [Related]
10. CORE breast-cancer prevention trial.
Bradbury J
Lancet Oncol; 2005 Jan; 6(1):8. PubMed ID: 15672490
[No Abstract] [Full Text] [Related]
11. Update in general internal medicine.
Mincey BA
Ann Intern Med; 2001 Aug; 135(4):300-1. PubMed ID: 11511149
[No Abstract] [Full Text] [Related]
12. Beyond raloxifene for the prevention of osteoporosis and breast cancer.
Jordan VC
Br J Pharmacol; 2007 Jan; 150(1):3-4. PubMed ID: 17115068
[TBL] [Abstract][Full Text] [Related]
13. [Raloxifene hydrochloride (Evista Tablet 60 mg) for postmenopausal osteoporosis: mode of action and clinical efficacy].
Kobayashi H; Hamaya E
Nihon Yakurigaku Zasshi; 2005 Jan; 125(1):37-48. PubMed ID: 15738620
[No Abstract] [Full Text] [Related]
14. [Molecular mechanism tissue-specific actions of selective estrogen receptor modulators].
Urano T
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):147-51. PubMed ID: 16683636
[No Abstract] [Full Text] [Related]
15. The science of selective estrogen receptor modulators: concept to clinical practice.
Jordan VC
Clin Cancer Res; 2006 Sep; 12(17):5010-3. PubMed ID: 16951214
[No Abstract] [Full Text] [Related]
16. Breast cancer prevention.
Rodabaugh KJ; Bloss JD
Clin Obstet Gynecol; 2001 Sep; 44(3):478-84. PubMed ID: 11685873
[No Abstract] [Full Text] [Related]
17. [What do we think about selective estrogen receptor modulators?].
Cortet B
Rev Med Interne; 2001 Dec; 22(12):1173-6. PubMed ID: 11794886
[No Abstract] [Full Text] [Related]
18. Raloxifene: risks and benefits.
Barrett-Connor E
Ann N Y Acad Sci; 2001 Dec; 949():295-303. PubMed ID: 11795366
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Land SR; Wickerham DL; Costantino JP; Ritter MW; Vogel VG; Lee M; Pajon ER; Wade JL; Dakhil S; Lockhart JB; Wolmark N; Ganz PA
JAMA; 2006 Jun; 295(23):2742-51. PubMed ID: 16754728
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of postmenopausal osteoporosis with raloxifene].
Fedelesova V; Chylova K; Dzurik
Bratisl Lek Listy; 2000; 101(9):527-8. PubMed ID: 11187059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
